Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Biomarin Pharmaceuticals (BMRN)
Biomarin Pharmaceuticals (BMRN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 17,150,242
  • Shares Outstanding, K 187,701
  • Annual Sales, $ 2,096 M
  • Annual Income, $ 141,560 K
  • 60-Month Beta 0.38
  • Price/Sales 8.26
  • Price/Cash Flow 61.76
  • Price/Book 3.67
Trade BMRN with:

Options Overview Details

View History
  • Implied Volatility 41.52% ( -2.38%)
  • Historical Volatility 28.99%
  • IV Percentile 83%
  • IV Rank 62.62%
  • IV High 50.22% on 06/16/22
  • IV Low 26.95% on 01/26/23
  • Put/Call Vol Ratio 1.34
  • Today's Volume 354
  • Volume Avg (30-Day) 964
  • Put/Call OI Ratio 0.42
  • Today's Open Interest 45,413
  • Open Int (30-Day) 41,179

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 21 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/23
See More
  • Average Estimate 0.23
  • Number of Estimates 11
  • High Estimate 0.30
  • Low Estimate 0.17
  • Prior Year 0.33
  • Growth Rate Est. (year over year) -30.30%

Price Performance

See More
Period Period Low Period High Performance
1-Month
85.66 +6.67%
on 06/01/23
96.47 -5.29%
on 05/15/23
-4.24 (-4.43%)
since 05/09/23
3-Month
85.66 +6.67%
on 06/01/23
100.38 -8.98%
on 04/17/23
-1.62 (-1.74%)
since 03/09/23
52-Week
70.73 +29.18%
on 06/14/22
117.77 -22.42%
on 01/27/23
+14.71 (+19.19%)
since 06/09/22

Most Recent Stories

More News
3 Biotech Stocks Poised to Skyrocket

On the backs of successful trials and breakthrough therapies, the biotech market is poised to thrive. Therefore, scooping up the shares of fundamentally sound biotech stocks such as BioMarin Pharmaceutical...

BMRN : 91.37 (-0.96%)
INCY : 61.04 (-0.76%)
INVA : 13.30 (-3.06%)
MOR : 7.46 (-0.40%)
BioMarin to Participate in Bank of America 2023 Health Care Conference

/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Brian Mueller, Executive Vice President, Chief Financial Officer of BioMarin...

BMRN : 91.37 (-0.96%)
New Strong Sell Stocks for May 1st

AOMR, BMRN and CUTR have been added to the Zacks Rank #5 (Strong Sell) List on May 1, 2023.

BMRN : 91.37 (-0.96%)
CUTR : 17.87 (-3.72%)
AOMR : 7.36 (-6.12%)
BioMarin (BMRN) Q1 Earnings Top, Voxzogo Drives Sales

BioMarin (BMRN) reports encouraging first-quarter results, wherein both earnings and sales beat estimates. The rapid uptake of Voxzogo boosts revenues.

SNY : 51.24 (-0.58%)
BMRN : 91.37 (-0.96%)
LGND : 73.76 (-0.70%)
OCUP : 3.76 (-5.05%)
BioMarin (BMRN) Reports Q1 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for BioMarin (BMRN) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to...

BMRN : 91.37 (-0.96%)
BioMarin Pharmaceutical (BMRN) Q1 Earnings and Revenues Surpass Estimates

BioMarin (BMRN) delivered earnings and revenue surprises of 39.53% and 4.17%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

BMRN : 91.37 (-0.96%)
GTHX : 2.76 (-2.47%)
BioMarin: Q1 Earnings Snapshot

BioMarin: Q1 Earnings Snapshot

BMRN : 91.37 (-0.96%)
BioMarin Announces Record Breaking First Quarter 2023 Results, Including 15% Year-over-year Growth of Total Revenues

Growth of VOXZOGO® Accelerated with Rapid Uptake in Japan and Brazil Resulting in Increased Full-year 2023 Guidance Full-year 2023 Top-line and Bottom-line...

BMRN : 91.37 (-0.96%)
BioMarin to Host First Quarter 2023 Financial Results Conference Call and Webcast on Wednesday, April 26, at 4:30pm ET

/PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will...

BMRN : 91.37 (-0.96%)
Is Invesco Dynamic Biotechnology & Genome ETF (PBE) a Strong ETF Right Now?

Smart Beta ETF report for PBE

PBE : 62.40 (-0.82%)
BMRN : 91.37 (-0.96%)
GILD : 78.12 (-0.36%)
INCY : 61.04 (-0.76%)
IBB : 128.84 (-0.15%)
XBI : 87.66 (-0.52%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

BioMarin Pharmaceutical Inc. focuses on the development and commercialization of treatments for serious life-threatening medical conditions, mostly for children. The company's portfolio comprises seven marketed products namely, Aldurazyme, Naglazyme, Kuvan a rare genetic enzyme deficiency disorder),...

See More

Key Turning Points

3rd Resistance Point 93.07
2nd Resistance Point 92.65
1st Resistance Point 92.01
Last Price 91.37
1st Support Level 90.96
2nd Support Level 90.54
3rd Support Level 89.90

See More

52-Week High 117.77
Fibonacci 61.8% 99.80
Fibonacci 50% 94.25
Last Price 91.37
Fibonacci 38.2% 88.70
52-Week Low 70.73

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar